Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: Potential role in anti-atherosclerotic activity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chinese Journal of Integrative Medicine

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11655-012-1213-9PMID 23001464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3‐kinase/Akt‐dependent pathway in diabetic rats

  2010cited by this paper
• Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.

  2010cited by this paper
• Effects of tanshinone II A on the myocardial hypertrophy signal transduction system protein kinase B in rats

  2009cited by this paper
• Effects of Tanshinone IIA on the Myocardial Hypertrophy Signal Transduction System Protein Kinase B in Rats

  2009cited by this paper
• Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.

  2008cited by this paper
• Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation

  2008cited by this paper
• Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit.

  2008cited by this paper
• Effect of sodium tanshinone II A sulfonate on phosphorylation of extracellular signal-regulated kinase 1/2 in angiotensin II-induced hypertrophy of myocardial cells

  2008cited by this paper
• Effect of sodium tanshinone II A sulfonate on cardiac myocyte hypertrophy and its underlying mechanism

  2008cited by this paper
• [Effects and mechanism of hyperglycemia on development and maturation and immune function of human monocyte derived dendritic cells].

  2006cited by this paper
• Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.

  2006cited by this paper
• The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis.

  2006cited by this paper
• Dendritic cells in atherosclerosis: current status of the problem and clinical relevance.

  2005cited by this paper
• Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

  2005cited by this paper
• Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells.

  2004cited by this paper
• Ciglitazone Inhibits Oxidized-Low Density Lipoprotein Induced Immune Maturation of Dendritic Cells

  2004cited by this paper
• Nicotine Strongly Activates Dendritic Cell–Mediated Adaptive Immunity: Potential Role for Progression of Atherosclerotic Lesions

  2003cited by this paper
• Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

  2003cited by this paper
• In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells.

  2003cited by this paper
• The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

  2002cited by this paper
• Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals

  2001cited by this paper
• Regulation of Immune Mechanisms in Atherosclerosis

  2001cited by this paper
• Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis.

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions.

  1998cited by this paper
• S-100 positive cells in human arterial intima and in atherosclerotic lesions.

  1995cited by this paper

• Plant-derived natural products targeting inflammation in treatment of atherosclerosis

  2025cites this paper
• Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases

  2025cites this paper
• Research Progress on Regulation of Immune Response by Tanshinones and Salvianolic Acids of Danshen (Salvia miltiorrhiza Bunge)

  2024cites this paper
• Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways

  2023cites this paper
• Research progress on the active ingredients of traditional Chinese medicine in the intervention of atherosclerosis: A promising natural immunotherapeutic adjuvant.

  2023cites this paper
• Therapeutic potential of traditional Chinese medicine in atherosclerosis: A review

  2022cites this paper
• Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network

  2020cites this paper
• Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases

  2020cites this paper
• Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway

  2019cites this paper
• Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications

  2019cites this paper
• Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen

  2018cites this paper
• Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine.

  2018cites this paper
• A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation

  2018cites this paper
• Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats

  2016cites this paper
• Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis

  2014cites this paper
• Sodium tanshinone IIA sulfonate prolongs the survival of skin allografts by inhibiting inflammatory cell infiltration and T cell proliferation.

  2014cites this paper